Improved workflow and performance from Pre-Op to PACU.

The AERIS^TM Kit simplifies every phase of care (pre, intra, and post-procedure) by streamlining the workflow while reducing healthcare costs.

The AERIS^TM Kit incorporates a detachable nasal cannula that allows for pre-oxygenation before sedation, then connects quickly to the AERIS Airway^TM for superior oxygen delivery and continuous ETCO₂ monitoring during the procedure and then can revert back to providing supplemental oxygen during transport to and while in PACU.

Transform standard airways into state-of-the-art O₂ delivery & CO₂ monitoring systems.

The AERIS Airway^TM seamlessly integrates and modernizes standard OPA and NPA devices into dual functioning systems – by providing superior oxygen delivery while capturing reliable ETCO₂ data in real time.

With the AERIS Airway^TM, 2-4 L/min of O2 flow produces FIO₂ levels approaching 90%, while providing precise, high quality ETCO₂ waveforms.

Superior oxygenation increases patient safety by reducing the risk of hypoxemia, and earlier detection of hypoventilation enables clinicians to detect any signs of respiratory compromise in sedated and post-op patients recovering in PACU.

In addition, following a general anesthesia procedure, if you perform deep extubation, you can place an OPA/AERIS Airway^TM to maintain the airway and provide supplemental oxygen while transporting the patient to PACU.

Versatility. Elegant simplicity.

The AERIS Airway^™ fits in all Guedel type OPAs sizes 80-110mm and all standard NPAs sizes 24-36Fr.

Higher FIO₂ at lower O2 flow rates - more reliable ETCO₂ monitoring – enhanced patient safety.

Unlike nasal cannulas and face masks that plateau at 21-45% FIO₂, the AERIS AirwayTM achieves 80-90% FIO₂ at lower oxygen flow rates of 2-4 L/min, thereby reducing the risk of hypoxemia.

In addition, the AERIS Airway^TM produces a high-fidelity, precise ETCO₂ waveform that helps clinicians pre-emptively detect respiratory compromise, while divided nasal cannulas and face masks produce ETCO₂ waveforms of lower fidelity, thereby having less clinical utility.

Versatile. Simple. Effective.

Any moderate to deep I.V. sedation procedure utilizing an OPA or NPA would benefit using an AERIS Airway^TM. Examples include pain management, orthopedics, arthroscopy, podiatric surgery, plastic surgery, hernia repair, ENT, and gynecology procedures.

With AERIS^TM, an OPA or NPA is no longer solely a device for maintaining an open airway. The AERIS Airway^TM provides advanced oxygenation and capnography capabilities while reducing risk during sedation procedures.

Dual precision. Superior performance.

The AERIS Airway^TM produces precise, high-fidelity ETCO₂ waveforms while it delivers FIO₂ approaching 80-90% due to its dual port design.

The AERIS^TM Airway has a CO₂ detection port that is distal to the O₂ delivery port, thereby ensuring continuous, accurate, and real-time ETCO₂ sampling at the supraglottic region.

The AERIS Airway^TM offers superior oxygenation and real-time, reliable ETCO₂ waveforms in one integrated system.

Elegantly simple. Highly efficient.

Transform any standard Guedel-type OPA or NPA into a highly efficient oxygen delivery and ETCO₂ monitoring system in seconds. It is as easy as 1-2-3!

1. Confirm: connect O₂ and CO₂ lines to the AERIS Airway^TM and confirm oxygen is freely flowing through the device prior to placing into OPA/NPA.
2. Insert: guide the distal tip of the AERIS Airway^TM into the central lumen of an OPA or NPA airway until the proximal hub rests on the flange of the OPA/NPA.
3. Position:
   a. OPA – the AERIS Airway^TM connection ports and tubing can be oriented towards the feet or head. 
   b. NPA – insert AERIS Airway^TM in any orientation that allows full insertion into NPA.

Universal compatibility. Effortless integration.

Yes, each AERIS Airway^TM Kit includes a 10-foot dual O₂ & CO₂ line with universal connectors that fit seamlessly with all standard oxygen sources. AERIS^TM is fully compatible with all patient monitors utilizing MALE, FEMALE or Microstream® MSA connectors – ensuring quick setup and reliable performance in any clinical environment.

FDA Class 1 510(k) exempt device.

The AERIS Airway^TM is a Class 1 medical device, considered to be low-risk, and therefore does not receive FDA approval. Instead, manufacturers are required to register their facility and list their devices with the FDA, follow proper labeling and Good Manufacturing Practices (GMPs), and maintain recordkeeping and reporting of any adverse events.